deep drawdown masks durable recurring model
WKL looks like a compelling value opportunity because the stock is down ~64% in 14 months, it still generates ~83% recurring revenue with ~9% free-cash-flow yield and a low-teens valuation (P around ~10–11) while remaining entrenched in health/tax/financial/legal-regulatory niches and using AI to support operations, even though forward growth is guided to low single digits.
Despite a ~64% decline over 14 months, WKL retains ~83% recurring revenue, a ~9% free-cash-flow yield, and low-teens earnings multiple across entrenched health, tax, and legal-regulatory niches. AI integration supports operations while the valuation remains undemanding relative to cash generation.